Cargando…
Identification of a 20-Gene Expression-Based Risk Score as a Predictor of Clinical Outcome in Chronic Lymphocytic Leukemia Patients
Despite the improvement in treatment options, chronic lymphocytic leukemia (CLL) remains an incurable disease and patients show a heterogeneous clinical course requiring therapy for many of them. In the current work, we have built a 20-gene expression (GE)-based risk score predictive for patients ov...
Autores principales: | Bou Samra, Elias, Klein, Bernard, Commes, Thérèse, Moreaux, Jérôme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026849/ https://www.ncbi.nlm.nih.gov/pubmed/24883311 http://dx.doi.org/10.1155/2014/423174 |
Ejemplares similares
-
Development of gene expression-based risk score in cytogenetically normal acute myeloid leukemia patients
por: Bou Samra, Elias, et al.
Publicado: (2012) -
Gene expression-based risk score in diffuse large B-cell lymphoma
por: Bret, Caroline, et al.
Publicado: (2012) -
New chimeric RNAs in acute myeloid leukemia
por: Rufflé, Florence, et al.
Publicado: (2017) -
Expression and role of RIP140/NRIP1 in chronic lymphocytic leukemia
por: Lapierre, Marion, et al.
Publicado: (2015) -
Autoimmune cytopenias in chronic lymphocytic leukemia
por: Haider, M. Shabih, et al.
Publicado: (2019)